Survival of cardiac resynchronisation therapy patients with and without defibrillator: Real-world evidence from the observational part of the RESET-CRT project.

3 April 2022 (14:43 - 14:51)

Organised by:

Video

Sign in for access options

Slides

9 More presentations in this session

Presentation thumbnail

Cardiac magnetic resonance imaging for prediction of risk for sudden cardiac death after myocardial infarction, the updated PROFID clinical prediction model

Presentation thumbnail

The updated PROFID clinical prediction model - discussion.

Presentation thumbnail

Conduction system pacing vs. biventricular pacing in Heart Failure and wide QRS patients: a randomized study

Presentation thumbnail

Conduction system pacing vs. biventricular pacing in Heart Failure and wide QRS patients: a randomized study - discussion.

Presentation thumbnail

Multicentre European left bundle branch area pacing outcomes study: MELOS

Access the full session

Session thumbnail

Late Breaking Clinical Trials I - devices and prevention sudden cardiac death

The Event

Event poster

EHRA 2022

3 April 2022 14:43 CET

You may be interested in

Congress Presentation

Cardiac resynchronisation therapy: the role of the defibrillator

9 April 2024

Congress Presentation

Cardiac resynchronization therapy - beyond ejection fraction

12 May 2024

Congress Presentation

CRT-P vs CRT-D in non-ischemic cardiomyopathy: still a matter of debate

19 May 2025

Congress Presentation

Cardiac resynchronization therapy: an enabler for GDMT optimization in HFrEF? Data from the Swedish Heart Failure and the Swedish Pacemaker and Implantable Cardioverter-Defibrillator Registries.

19 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources